Search - tctmd.com

Displaying 121 - 140 of 154

Sort: Relevancy | Date

News Daily News

El Riesgo de ACV de las Oclusiones Carotídeas parece Muy Bajo en Pacientes Asintomáticos Contemporáneos

September 29, 2015

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

L.A. McKeown

September 01, 2015

Presentation

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Presenter: Sanjit S. Jolly

July 13, 2015

News Industry News

UK launch for Daiichi's bloodthinner Lixiana

July 10, 2015

News Opinion Editor's Corner

Endovascular Therapy for Stroke: What Has Changed?

Caitlin E. Cox

February 23, 2015

News Daily News

Vorapaxar可以防范意外缺血性卒中、支架内血栓形成

Todd Neale

December 04, 2014

News Daily News

Vorapaxar podría Proteger frente a ACV Isquémicos Incidentales y Trombosis del Stent

Todd Neale

December 04, 2014

News Daily News

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

Todd Neale

December 04, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Daily News

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

Leah Lawrence

July 03, 2014

Presentation

National Trends in Stroke after AMI: 1999-2010

Presenter: Y. Wang

June 27, 2014

News Daily News

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

L.A. McKeown

March 27, 2014

Advertisement

El Riesgo de ACV de las Oclusiones Carotídeas parece Muy Bajo en Pacientes Asintomáticos Contemporáneos

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

UK launch for Daiichi's bloodthinner Lixiana

Endovascular Therapy for Stroke: What Has Changed?

Vorapaxar可以防范意外缺血性卒中、支架内血栓形成

Vorapaxar podría Proteger frente a ACV Isquémicos Incidentales y Trombosis del Stent

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

National Trends in Stroke after AMI: 1999-2010

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content